NADAC acquisition cost data for WATER FOR INJECTION VIAL. This is a generic medication, typically more affordable than brand-name equivalents.
| Generic Name | Water for Injection |
| Brand Name | Diluent Component |
| Manufacturer | Bavarian Nordic A/S |
| Dosage Form | LIQUID |
| Route | SUBCUTANEOUS |
| Product Type | VACCINE |
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00409488710 | $0.0823 | 2022-07-20 | Rx |
| 00517301025 | $0.0823 | 2022-07-20 | Rx |
| 63323018510 | $0.0823 | 2022-07-20 | Rx |
| 00409488710 | $0.0823 | 2022-07-20 | Rx |
| 00517301025 | $0.0823 | 2022-07-20 | Rx |
| 63323018510 | $0.0823 | 2022-07-20 | Rx |
| 00409488710 | $0.0823 | 2022-07-20 | Rx |
| 00517301025 | $0.0823 | 2022-07-20 | Rx |
| 63323018510 | $0.0823 | 2022-07-20 | Rx |
| 00409488710 | $0.0823 | 2022-07-20 | Rx |
Generic: Water For Irrigation,Sterile | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $351.2K | 16,461 | 6,175 | $0.007064 |
| 2020 | $411.7K | 16,507 | 5,414 | $0.007067 |
| 2021 | $455.0K | 16,930 | 5,009 | $0.007620 |
| 2022 | $439.0K | 16,243 | 4,607 | $0.008932 |
| 2023 | $521.3K | 17,322 | 5,352 | $0.0110 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| New York | $111.9K | 2,878 | 1,046 |
| California | $60.0K | 1,560 | 388 |
| Ohio | $56.7K | 1,819 | 440 |
| Pennsylvania | $32.1K | 911 | 255 |
| Florida | $23.2K | 772 | 238 |
| Indiana | $20.7K | 919 | 306 |
| Arizona | $18.9K | 345 | 124 |
| Massachusetts | $15.7K | 388 | 59 |
| Minnesota | $15.0K | 664 | 175 |
| Alaska | $11.3K | 115 | 57 |
| Washington | $10.9K | 405 | 128 |
| Connecticut | $10.2K | 345 | 66 |
| Missouri | $9.8K | 326 | 107 |
| North Carolina | $9.2K | 289 | 109 |
| Texas | $8.7K | 499 | 235 |
| Tennessee | $8.6K | 353 | 124 |
| Utah | $7.8K | 296 | 58 |
| Illinois | $7.5K | 516 | 179 |
| Kentucky | $6.4K | 246 | 117 |
| Wisconsin | $6.3K | 410 | 129 |
| Kansas | $5.9K | 281 | 109 |
| Georgia | $5.8K | 188 | 91 |
| Michigan | $5.5K | 383 | 116 |
| Virginia | $5.3K | 212 | 65 |
| Oregon | $5.1K | 182 | 32 |
| Iowa | $4.9K | 194 | 60 |
| New Jersey | $4.9K | 202 | 69 |
| Arkansas | $4.4K | 166 | 43 |
| Colorado | $3.3K | 158 | 56 |
| Oklahoma | $2.8K | 234 | 69 |
| South Carolina | $2.2K | 97 | 34 |
| Nevada | $2.2K | 39 | N/A |
| Nebraska | $2.1K | 114 | 37 |
| Maryland | $1.7K | 126 | 67 |
| District of Columbia | $1.4K | 19 | N/A |
| Hawaii | $1.4K | 40 | 12 |
| South Dakota | $1.3K | 52 | 17 |
| Alabama | $1.1K | 57 | 13 |
| Idaho | $1.0K | 45 | 18 |
| Rhode Island | $989.51 | 73 | 16 |
| Maine | $927.39 | 65 | 15 |
| North Dakota | $898.40 | 31 | 14 |
| Louisiana | $888.91 | 107 | 28 |
| West Virginia | $840.65 | 25 | N/A |
| Delaware | $806.96 | 33 | 13 |
| New Hampshire | $630.27 | 29 | N/A |
| Montana | $563.76 | 25 | 14 |
| Puerto Rico | $395.71 | 13 | N/A |
| New Mexico | $394.22 | 19 | N/A |
| Wyoming | $371.98 | 29 | 11 |
| Vermont | $325.21 | 18 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.
Explore More Data Tools
For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.